Cargando…

The m(6)A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway

BACKGROUND: Chemoresistance is a major factor contributing to the poor prognosis of patients with pancreatic cancer, and cancer stemness is one of the most crucial factors associated with chemoresistance and a very promising direction for cancer treatment. However, the exact molecular mechanisms of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi, Liu, Xiaomeng, Wang, Yan, Lai, Shihui, Wang, Zhiqian, Yang, Yudie, Liu, Wenhui, Wang, Hongquan, Tang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438157/ https://www.ncbi.nlm.nih.gov/pubmed/36056355 http://dx.doi.org/10.1186/s12943-022-01647-0

Ejemplares similares

Circulating levels of DDIT4 and mTOR, and contributions of BMI, inflammation and insulin sensitivity in hyperlipidemia
por: Pan, Xinyan, et al.
Publicado: (2022)

PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4
por: Salsman, Jayme, et al.
Publicado: (2017)

Omeprazole improves chemosensitivity of gastric cancer cells by m(6)A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation
por: Feng, Shuitu, et al.
Publicado: (2021)

The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
por: Foltyn, Martha, et al.
Publicado: (2019)

mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters
por: Liu, Yuanhui, et al.
Publicado: (2022)

Mammalian ALKBH1 serves as an N(6)-mA demethylase of unpairing DNA
por: Zhang, Min, et al.
Publicado: (2020)

Resveratrol improves palmitic acid‑induced insulin resistance via the DDIT4/mTOR pathway in C2C12 cells
por: Pan, Xinyan, et al.
Publicado: (2023)

The biological function of m6A demethylase ALKBH5 and its role in human disease
por: Wang, Jinyan, et al.
Publicado: (2020)

RNA m(6)A demethylase ALKBH5 regulates the development of γδ T cells
por: Ding, Chenbo, et al.
Publicado: (2022)

DDIT4 regulates mesenchymal stem cell fate by mediating between HIF1α and mTOR signalling
por: Gharibi, Borzo, et al.
Publicado: (2016)

p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance
por: Coronel, Luis, et al.
Publicado: (2021)

Role of Autophagy Mediated by AMPK/DDiT4/mTOR Axis in HT22 Cells Under Oxygen and Glucose Deprivation/Reoxygenation
por: Zhang, Yi, et al.
Publicado: (2023)

Endothelial mTOR maintains hematopoiesis during aging
por: Ramalingam, Pradeep, et al.
Publicado: (2020)

Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis
por: Viscarra, Jose A., et al.
Publicado: (2020)

Phf8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway
por: Chen, Xuemei, et al.
Publicado: (2018)

Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification
por: Hu, Yiyang, et al.
Publicado: (2022)

Suxiao Jiuxin Pill alleviates myocardial ischemia–reperfusion injury through the ALKBH5/GSK3β/mTOR pathway
por: Li, Yiping, et al.
Publicado: (2023)

m(6)A demethylase ALKBH5 controls CD4(+) T cell pathogenicity and promotes autoimmunity
por: Zhou, Jing, et al.
Publicado: (2021)

The DEAD-Box RNA Helicase DDX3 Interacts with m(6)A RNA Demethylase ALKBH5
por: Shah, Abdullah, et al.
Publicado: (2017)

Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
por: Westhoff, Mike-Andrew, et al.
Publicado: (2013)

PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

m(6)A demethylase ALKBH5 is required for antibacterial innate defense by intrinsic motivation of neutrophil migration
por: Liu, Yang, et al.
Publicado: (2022)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

m(6)A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression
por: Xiao, Dong, et al.
Publicado: (2021)

Impact of m6A demethylase (ALKBH5, FTO) genetic polymorphism and expression levels on the development of pulmonary tuberculosis
por: Zhang, Tian-Ping, et al.
Publicado: (2022)

ALKBH10B, an mRNA m(6)A Demethylase, Modulates ABA Response During Seed Germination in Arabidopsis
por: Tang, Jun, et al.
Publicado: (2021)

The RNA Demethylase ALKBH5 Maintains Endoplasmic Reticulum Homeostasis by Regulating UPR, Autophagy, and Mitochondrial Function
por: Subbarayalu, Panneerdoss, et al.
Publicado: (2023)

The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA
por: Li, Xiao-Cui, et al.
Publicado: (2019)

mTOR as a Key Regulator in Maintaining Skeletal Muscle Mass
por: Yoon, Mee-Sup
Publicado: (2017)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors
por: Selberg, Simona, et al.
Publicado: (2021)

The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells
por: Kowalski-Chauvel, Aline, et al.
Publicado: (2020)

N6‐methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation
por: Zhang, Zhen, et al.
Publicado: (2022)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

Deubiquitinase USP9X stabilizes RNA m(6)A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival
por: Wang, Peipei, et al.
Publicado: (2023)

Long noncoding RNA CCAT2 reduces chemosensitivity to 5‐fluorouracil in breast cancer cells by activating the mTOR axis
por: Zhou, Daoping, et al.
Publicado: (2022)

mTOR inhibitors in cancer therapy
por: Xie, Jianling, et al.
Publicado: (2016)

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
por: Qu, Jianwei, et al.
Publicado: (2022)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oqkkpkug8mppbb27b6g2i7igfh